These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9049966)

  • 1. Interferon-inducible protein-10 and the pathogenesis of cutaneous T-cell lymphomas.
    Sarris AH; Daliani D; Ulmer R; Crow M; Broxmeyer HE; Pugh W; Reiss M; Cabanillas F; Deisseroth AB; Duvic M
    Leuk Lymphoma; 1996 Dec; 24(1-2):103-10. PubMed ID: 9049966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-inducible protein 10 as a possible factor in the pathogenesis of cutaneous T-cell lymphomas.
    Sarris AH; Daliani D; Ulmer R; Crow M; Broxmeyer HE; Reiss M; Karasavvas N; Zelenetz AD; Pugh W; Cabanillas F; Deisseroth AB; Duvic M
    Clin Cancer Res; 1997 Feb; 3(2):169-77. PubMed ID: 9815669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine loops involving interferon-gamma and IP-10, a cytokine chemotactic for CD4+ lymphocytes: an explanation for the epidermotropism of cutaneous T-cell lymphoma?
    Sarris AH; Esgleyes-Ribot T; Crow M; Broxmeyer HE; Karasavvas N; Pugh W; Grossman D; Deisseroth A; Duvic M
    Blood; 1995 Jul; 86(2):651-8. PubMed ID: 7605995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal interferon-gamma inducible protein-10 (IP-10) and monokine induced by gamma-interferon (Mig) but not IL-8 mRNA expression is associated with epidermotropism in cutaneous T cell lymphomas.
    Tensen CP; Vermeer MH; van der Stoop PM; van Beek P; Scheper RJ; Boorsma DM; Willemze R
    J Invest Dermatol; 1998 Aug; 111(2):222-6. PubMed ID: 9699721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor-alpha and interferon-gamma, but not HTLV-I tax, are likely factors in the epidermotropism of cutaneous T-cell lymphoma via induction of interferon-inducible protein-10.
    Daliani D; Ulmer RA; Jackow C; Pugh W; Gansbacher B; Cabanillas F; Duvic M; Sarris AH
    Leuk Lymphoma; 1998 Apr; 29(3-4):315-28. PubMed ID: 9684929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low herpesvirus entry mediator (HVEM) expression on dermal fibroblasts contributes to a Th2-dominant microenvironment in advanced cutaneous T-cell lymphoma.
    Miyagaki T; Sugaya M; Suga H; Morimura S; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    J Invest Dermatol; 2012 Apr; 132(4):1280-9. PubMed ID: 22297640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermal infiltrates of cutaneous T-cell lymphomas with epidermotropism but not other cutaneous lymphomas are abundant with langerin⁺ dendritic cells.
    Der-Petrossian M; Valencak J; Jonak C; Klosner G; Dani T; Müllauer L; Pehamberger H; Knobler R; Trautinger F
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):922-7. PubMed ID: 21054571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro induction of basal keratinocyte MY7 antigen expression in cutaneous T-cell lymphoma is associated with response to interferon-alfa therapy.
    Celerier P; Fleischmann M; Basset-Seguin N; Thill L; Bureau B; Litoux P; Dréno B
    Arch Dermatol; 1993 Sep; 129(9):1136-40. PubMed ID: 8103318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudoepitheliomatous hyperplasia in cutaneous T-cell lymphoma. A clinical, histopathological and immunohistochemical study with particular interest in epithelial growth factor expression. The French Study Group on Cutaneous Lymphoma.
    Courville P; Wechsler J; Thomine E; Vergier B; Fonck Y; Souteyrand P; Beylot-Barry M; Bagot M; Joly P
    Br J Dermatol; 1999 Mar; 140(3):421-6. PubMed ID: 10233260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human IP-9: A keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3).
    Tensen CP; Flier J; Van Der Raaij-Helmer EM; Sampat-Sardjoepersad S; Van Der Schors RC; Leurs R; Scheper RJ; Boorsma DM; Willemze R
    J Invest Dermatol; 1999 May; 112(5):716-22. PubMed ID: 10233762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal interleukin 1 alpha functional activity and interleukin 8 immunoreactivity are increased in patients with cutaneous T-cell lymphoma.
    Hansen ER; Vejlsgaard GL; Lisby S; Heidenheim M; Baadsgaard O
    J Invest Dermatol; 1991 Nov; 97(5):818-23. PubMed ID: 1919047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenin levels are increased in lesional skin and sera in patients with erythrodermic cutaneous T cell lymphoma.
    Miyagaki T; Sugaya M; Suga H; Akamata K; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    Arch Dermatol Res; 2012 Jul; 304(5):401-6. PubMed ID: 22526325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrins alpha4beta7 and alphaEbeta7 are expressed on epidermotropic T cells in cutaneous T cell lymphoma and spongiotic dermatitis.
    Schechner JS; Edelson RL; McNiff JM; Heald PW; Pober JS
    Lab Invest; 1999 May; 79(5):601-7. PubMed ID: 10334571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines.
    Giustizieri ML; Mascia F; Frezzolini A; De Pità O; Chinni LM; Giannetti A; Girolomoni G; Pastore S
    J Allergy Clin Immunol; 2001 May; 107(5):871-7. PubMed ID: 11344355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strong expression of the lymphoattractant C-X-C chemokine Mig is associated with heavy infiltration of T cells in human malignant melanoma.
    Kunz M; Toksoy A; Goebeler M; Engelhardt E; Bröcker E; Gillitzer R
    J Pathol; 1999 Dec; 189(4):552-8. PubMed ID: 10629557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Interleukin-19 Expression in Cutaneous T-cell Lymphoma and Atopic Dermatitis.
    Oka T; Sugaya M; Takahashi N; Nakajima R; Otobe S; Kabasawa M; Suga H; Miyagaki T; Asano Y; Sato S
    Acta Derm Venereol; 2017 Nov; 97(10):1172-1177. PubMed ID: 28597022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BAFF levels are increased in lesional skin and sera in patients with cutaneous T-cell lymphoma.
    Ohmatsu H; Sugaya M; Miyagaki T; Suga H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    Br J Dermatol; 2012 Aug; 167(2):359-67. PubMed ID: 22512719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma.
    Miyagaki T; Sugaya M; Suga H; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    Clin Cancer Res; 2011 Dec; 17(24):7529-38. PubMed ID: 22048239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glu-Leu-Arg-negative CXC chemokine interferon gamma inducible protein-9 as a mediator of epidermal-dermal communication during wound repair.
    Satish L; Yager D; Wells A
    J Invest Dermatol; 2003 Jun; 120(6):1110-7. PubMed ID: 12787142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YKL-40 Promotes Proliferation of Cutaneous T-Cell Lymphoma Tumor Cells through Extracellular Signal-Regulated Kinase Pathways.
    Suzuki H; Boki H; Kamijo H; Nakajima R; Oka T; Shishido-Takahashi N; Suga H; Sugaya M; Sato S; Miyagaki T
    J Invest Dermatol; 2020 Apr; 140(4):860-868.e3. PubMed ID: 31622598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.